By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
In Zimbabwe, there is a thriving industry for the production of pharmaceuticals, with a number of local businesses creating a variety of pharmaceutical goods like generic medications, medical equipment, and herbal cures.
To lessen the nation’s dependency on pharmaceutical imports, local manufacture is being promoted.
Despite expanding its domestic manufacturing capabilities, Zimbabwe still imports a sizable share of its pharmaceutical goods, including finished goods and active pharmaceutical ingredients (APIs).
The need for a variety of healthcare products is met in part by these imports.
Zimbabwe places a high premium on ensuring access to necessary medications.
Price limits and subsidies for necessary medications are just two of the measures and policies that have been put in place to increase accessibility and affordability.
The Zimbabwe pharmaceutical market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
Zimbabwe introduced a manufacturing plan for pharmaceuticals to increase medicine production.
Additionally, by making more of the nation’s vital medications available, the approach is anticipated to enhance the pharmaceutical industry’s commitment to public health. Drug surplus will be exported.
Due to their medical aid societies only covering the prescribed rates for a limited number of medications, many persons who rely on medical assistance today face significant deficits when purchasing medications.
Even worse, those who do not receive medical assistance frequently forego taking recommended medications because they cannot pay the hefty costs.
Making medications available and inexpensive to citizens is the main goal of the Pharmaceutical Development Strategy.
The majority of Zimbabwe’s medications are pricey because only 12% of the medications used locally are now produced in Zimbabwe; the remainder are imported.
Consequently, it is anticipated that the Pharmaceutical Manufacturing Strategy will address that.
There are public health difficulties in Zimbabwe, such as HIV/AIDS, malaria, and problems with mother and child health.
The government executes a variety of health programmes, including disease control measures and immunisation campaigns, in cooperation with international organisations like the World Health Organisation (WHO) and UNICEF to address these difficulties
